Associated Papers
Trans-activating mutations of the pseudokinase ERBB3.
Koivu MKA et al.
Oncogene, 2024
38806620 (PubMed )
Supplement: 41388_2024_3070_MOESM2_ESM.xlsx › Excel_for_Processed_NGS_data
PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients.
Kim JW et al.
Cancer Research and Treatment, 2023
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer.
Loree JM et al.
Journal of the National Cancer Institute, 2018
Select a paper to view details